tradingkey.logo

AngioDynamics Inc

ANGO
13.100USD
-0.060-0.46%
收盤 12/26, 16:00美東報價延遲15分鐘
542.95M總市值
虧損本益比TTM

AngioDynamics Inc

13.100
-0.060-0.46%

關於 AngioDynamics Inc 公司

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

AngioDynamics Inc簡介

公司代碼ANGO
公司名稱AngioDynamics Inc
上市日期May 27, 2004
CEOClemmer (James C)
員工數量675
證券類型Ordinary Share
年結日May 27
公司地址14 Plaza Drive
城市LATHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編12110
電話15187981215
網址https://www.angiodynamics.com/
公司代碼ANGO
上市日期May 27, 2004
CEOClemmer (James C)

AngioDynamics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
66.46M
87.78%
International
9.26M
12.22%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
其他
65.84%
持股股東
持股股東
佔比
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
其他
65.84%
股東類型
持股股東
佔比
Investment Advisor
36.53%
Investment Advisor/Hedge Fund
35.68%
Hedge Fund
21.31%
Individual Investor
6.44%
Research Firm
1.99%
Pension Fund
1.68%
Bank and Trust
0.25%
Venture Capital
0.06%
Insurance Company
0.03%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Divisadero Street Capital Management, LP
3.40M
8.24%
+2.44M
+253.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.96M
7.2%
-94.58K
-3.09%
Jun 30, 2025
Systematic Financial Management, L.P.
2.51M
6.09%
+12.62K
+0.51%
Jun 30, 2025
Point72 Asset Management, L.P.
1.95M
4.73%
+1.02M
+109.86%
Jun 30, 2025
The Vanguard Group, Inc.
2.49M
6.04%
-3.33K
-0.13%
Jun 30, 2025
Millennium Management LLC
2.15M
5.21%
+746.42K
+53.34%
Jul 16, 2025
Armistice Capital LLC
1.53M
3.71%
-566.18K
-27.04%
Jun 30, 2025
Segall Bryant & Hamill, LLC
1.36M
3.29%
-27.75K
-2.00%
Jun 30, 2025
Bastion Asset Management Inc.
959.04K
2.33%
+304.22K
+46.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.85%
+7.01K
+0.60%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
查看更多
State Street SPDR S&P Health Care Equipment ETF
佔比0.79%
Invesco NASDAQ Future Gen 200 ETF
佔比0.63%
Vanguard US Multifactor ETF
佔比0.15%
iShares Micro-Cap ETF
佔比0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.07%
Fidelity Enhanced Small Cap ETF
佔比0.06%
Avantis US Small Cap Equity ETF
佔比0.06%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.04%
iShares Russell 2000 Value ETF
佔比0.02%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

AngioDynamics Inc的前五大股東是誰?

AngioDynamics Inc的前五大股東如下:
Divisadero Street Capital Management, LP
持有股份:3.40M
佔總股份比例:8.24%。
BlackRock Institutional Trust Company, N.A.
持有股份:2.96M
佔總股份比例:7.20%。
Systematic Financial Management, L.P.
持有股份:2.51M
佔總股份比例:6.09%。
Point72 Asset Management, L.P.
持有股份:1.95M
佔總股份比例:4.73%。
The Vanguard Group, Inc.
持有股份:2.49M
佔總股份比例:6.04%。

AngioDynamics Inc的前三大股東類型是什麼?

AngioDynamics Inc 的前三大股東類型分別是:
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.

有多少機構持有AngioDynamics Inc(ANGO)的股份?

截至2025Q4,共有311家機構持有AngioDynamics Inc的股份,合計持有的股份價值約為40.19M,占公司總股份的106.71% 。與2025Q3相比,機構持股有所增加,增幅為-2.34%。

哪個業務部門對AngioDynamics Inc的收入貢獻最大?

在FY2026Q1,--業務部門對AngioDynamics Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI